Actively Recruiting
Personalized Treatment of Urogenital Cancers Depends on the Microbiome
Led by Zealand University Hospital · Updated on 2024-01-30
28
Participants Needed
1
Research Sites
365 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a randomized controlled trial where patients undergoing surgical treatment for urogenital cancers will be randomized in a two arms study: surgical treatment + antibiotics OR surgical treatment + placebo.
CONDITIONS
Official Title
Personalized Treatment of Urogenital Cancers Depends on the Microbiome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Biopsy verified diagnosis of urological cancer, localized disease
You will not qualify if you...
- Hospitalization within three months of surgery
- Antibiotics within three months of surgery
- Infectious disease, including UTI's within three months of surgery
- History of cancers of the genitourinary tract
- Diabetes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zealand University Hospital
Roskilde, Denmark, 4000
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here